TY  - GEN
AU  - Behl,Ajay S
AU  - Goddard,Katrina A B
AU  - Flottemesch,Thomas J
AU  - Veenstra,David
AU  - Meenan,Richard T
AU  - Lin,Jennifer S
AU  - Maciosek,Michael V
TI  - Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer
SN  - 1460-2105
PY  - 2013///0204
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Confounding Factors, Epidemiologic
KW  - Cost-Benefit Analysis
KW  - Decision Support Techniques
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Genetic Testing
KW  - economics
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Quality-Adjusted Life Years
KW  - Research Design
KW  - United States
KW  - ras Proteins
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1093/jnci/djs433
ER  -